Advertisement

Index by author

September 01, 1987; Volume 242,Issue 3

A

  1. Abhold, R H

    1. Binding, degradation and pressor activity of angiotensins II and III after aminopeptidase inhibition with amastatin and bestatin.
      R H Abhold, M J Sullivan, J W Wright and J W Harding
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 957-962;

  2. Abiko, Y

    1. Inhibition of ischemia-induced subcellular redistribution of lysosomal enzymes in the perfused rat heart by the calcium entry blocker, diltiazem.
      K Ichihara, T Haneda, S Onodera and Y Abiko
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1109-1113;
    2. Effect of lidocaine on the myocardial acidosis induced by coronary artery occlusion in dogs.
      N Matsumura, H Matsumura and Y Abiko
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1114-1119;

  3. Allan, A M

    1. Neurochemical actions of anesthetic drugs on the gamma-aminobutyric acid receptor-chloride channel complex.
      J P Huidobro-Toro, V Bleck, A M Allan and R A Harris
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 963-969;

  4. Ardell, J L

    1. Selective ganglionic blockade of vagal inputs to sinoatrial and/or atrioventricular regions.
      J D Fee, W C Randall, R D Wurster and J L Ardell
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1006-1012;

B

  1. Barlow, J J

    1. ICI 147,798: a novel diuretic agent with beta adrenoceptor blocking activity.
      S T Kau, B B Howe, J H Li, L H Smith, J R Keddie, J J Barlow, R E Giles and M E Goldberg
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 818-826;

  2. Bass, A S

    1. Mechanisms mediating the positive inotropic and chronotropic changes induced by dopexamine in the anesthetized dog.
      A S Bass, J D Kohli, N Lubbers and L I Goldberg
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 940-944;

  3. Battaglia, G

    1. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
      G Battaglia, S Y Yeh, E O'Hearn, M E Molliver, M J Kuhar and E B De Souza
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 911-916;

  4. Benyon, R C

    1. Adenosine inhibits immunoglobulin E-dependent histamine secretion from human basophil leukocytes by two independent mechanisms.
      P J Hughes, R C Benyon and M K Church
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1064-1070;

  5. Berlan, M

    1. Characterization of dog fat cell adrenoceptors: variations in alpha-2 and beta adrenergic receptors distribution according to the extent of the fat deposits and the anatomical location.
      M Taouis, M Berlan, P Montastruc and M Lafontan
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1041-1049;

  6. Berson, G

    1. Protective effects of bepridil on calcium injury of anoxic myocytes isolated from adult rat heart ventricular muscle.
      C Cruz, A Zaoui, G Berson and A Younes
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1126-1132;

  7. Bevan, J A

    1. Diltiazem and autoregulation of canine cerebral blood flow.
      W J Pearce and J A Bevan
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 812-817;

  8. Bleck, V

    1. Neurochemical actions of anesthetic drugs on the gamma-aminobutyric acid receptor-chloride channel complex.
      J P Huidobro-Toro, V Bleck, A M Allan and R A Harris
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 963-969;

  9. Bozarth, J M

    1. Ca++ utilization in the constriction of rat aorta to stimulation of protein kinase C by phorbol dibutyrate.
      A T Chiu, J M Bozarth, M S Forsythe and P B Timmermans
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 934-939;

  10. Brodie, C

    1. Effects of ethanol on electrophysiological properties of rat skeletal myotubes in culture.
      C Brodie and S R Sampson
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1098-1103;
    2. Effects of chronic ethanol treatment on membrane potential, its electrogenic pump component and Na-K pump activity of cultured rat skeletal myotubes.
      C Brodie and S R Sampson
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1104-1108;

  11. Bylund, D B

    1. Characterization of the vasoactive intestinal peptide receptor in rat submandibular gland: radioligand binding assay in membrane preparations.
      J T Turner and D B Bylund
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 873-881;

C

  1. Campbell, K S

    1. Potentiation of the in vitro T-dependent antibody response by the B subunit of cholera toxin.
      K S Campbell and A E Munson
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 895-904;

  2. Cavero, I

    1. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
      P E Hicks, I Cavero, P Manoury, F Lefevre-Borg and S Z Langer
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1025-1034;

  3. Chait, L D

    1. Reinforcing and subjective effects of several anorectics in normal human volunteers.
      L D Chait, E H Uhlenhuth and C E Johanson
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 777-783;

  4. Chen, I W

    1. Differential effects of phenobarbital on ester and ether glucuronidation of diflunisal in rats.
      J H Lin, I W Chen, E H Ulm and D E Duggan
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1013-1018;

  5. Chiang, P K

    1. Comparison of in vitro actions with behavioral effects of antimuscarinic agents.
      J M Witkin, R K Gordon and P K Chiang
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 796-803;

  6. Chiu, A T

    1. Ca++ utilization in the constriction of rat aorta to stimulation of protein kinase C by phorbol dibutyrate.
      A T Chiu, J M Bozarth, M S Forsythe and P B Timmermans
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 934-939;

  7. Choca, J I

    1. Identification of A1 and A2 adenosine receptors in the rat spinal cord.
      J I Choca, H K Proudfit and R D Green
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 905-910;

  8. Church, M K

    1. Adenosine inhibits immunoglobulin E-dependent histamine secretion from human basophil leukocytes by two independent mechanisms.
      P J Hughes, R C Benyon and M K Church
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1064-1070;

  9. Civelli, M

    1. Characteristics and distribution of specific binding sites for leukotriene C4 in human bronchi.
      M Civelli, D Oliva, M Mezzetti and S Nicosia
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1019-1024;

  10. Cohen, M L

    1. In vitro vascular relaxation by new inotropic agents: relationship to phosphodiesterase inhibition and cyclic nucleotides.
      R F Kauffman, K W Schenck, B G Utterback, V G Crowe and M L Cohen
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 864-872;

  11. Corey, E J

    1. Relaxing effects of 15-lipoxygenase products of arachidonic acid on rat aorta.
      P Uotila, R Vargas, B Wroblewska, M d'Alarcao, S P Matsuda, E J Corey, C M Cunard and P W Ramwell
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 945-949;

  12. Costa, E

    1. In rat hippocampus, somatostatin 14 and muscarinic receptor ligands modulate an adenylate cyclase belonging to a common domain of the receptor.
      C Eva and E Costa
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 888-894;

  13. Cote, D T

    1. Pharmacological characterization of CGS 15943A: a novel nonxanthine adenosine antagonist.
      G Ghai, J E Francis, M Williams, R A Dotson, M F Hopkins, D T Cote, F R Goodman and M B Zimmerman
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 784-790;

  14. Coyle, D E

    1. Bupivacaine and lidocaine blockade of calcium-mediated slow action potentials in guinea pig ventricular muscle.
      D E Coyle and N Sperelakis
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1001-1005;

  15. Crews, F T

    1. Norepinephrine regulation of alpha-1 receptors and alpha-1-stimulated phosphoinositide hydrolysis in primary neuronal cultures.
      R A Gonzales, F T Crews, C Sumners and M K Raizada
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 764-771;

  16. Crowe, V G

    1. In vitro vascular relaxation by new inotropic agents: relationship to phosphodiesterase inhibition and cyclic nucleotides.
      R F Kauffman, K W Schenck, B G Utterback, V G Crowe and M L Cohen
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 864-872;

  17. Cruz, C

    1. Protective effects of bepridil on calcium injury of anoxic myocytes isolated from adult rat heart ventricular muscle.
      C Cruz, A Zaoui, G Berson and A Younes
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1126-1132;

  18. Cunard, C M

    1. Relaxing effects of 15-lipoxygenase products of arachidonic acid on rat aorta.
      P Uotila, R Vargas, B Wroblewska, M d'Alarcao, S P Matsuda, E J Corey, C M Cunard and P W Ramwell
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 945-949;

D

  1. d'Alarcao, M

    1. Relaxing effects of 15-lipoxygenase products of arachidonic acid on rat aorta.
      P Uotila, R Vargas, B Wroblewska, M d'Alarcao, S P Matsuda, E J Corey, C M Cunard and P W Ramwell
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 945-949;

  2. Daly, J W

    1. A1- and A2-selective adenosine antagonists: in vivo characterization of cardiovascular effects.
      G Evoniuk, K A Jacobson, M T Shamim, J W Daly and R J Wurtman
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 882-887;

  3. Davis, B B

    1. Lung prostaglandin H synthase and mixed-function oxidase metabolism of nicotine.
      M B Mattammal, V M Lakshmi, T V Zenser and B B Davis
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 827-832;

  4. Degott, C

    1. Inhibition of mitochondrial beta-oxidation of fatty acids by pirprofen. Role in microvesicular steatosis due to this nonsteroidal anti-inflammatory drug.
      J Geneve, B Hayat-Bonan, G Labbe, C Degott, P Letteron, E Freneaux, T L Dinh, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1133-1137;

  5. Delanney, L E

    1. 1,2,3,6-tetrahydro-1-methyl-4-(methylpyrrol-2-yl)pyridine: studies on the mechanism of action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
      K T Finnegan, I Irwin, L E Delanney, G A Ricaurte and J W Langston
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1144-1151;

  6. De Souza, E B

    1. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
      G Battaglia, S Y Yeh, E O'Hearn, M E Molliver, M J Kuhar and E B De Souza
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 911-916;

  7. Dinh, T L

    1. Inhibition of mitochondrial beta-oxidation of fatty acids by pirprofen. Role in microvesicular steatosis due to this nonsteroidal anti-inflammatory drug.
      J Geneve, B Hayat-Bonan, G Labbe, C Degott, P Letteron, E Freneaux, T L Dinh, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1133-1137;

  8. Dotson, R A

    1. Pharmacological characterization of CGS 15943A: a novel nonxanthine adenosine antagonist.
      G Ghai, J E Francis, M Williams, R A Dotson, M F Hopkins, D T Cote, F R Goodman and M B Zimmerman
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 784-790;

  9. Duffy, P

    1. Neurochemical and behavioral effects of corticotropin-releasing factor in the ventral tegmental area of the rat.
      P W Kalivas, P Duffy and L G Latimer
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 757-763;

  10. Duggan, D E

    1. Differential effects of phenobarbital on ester and ether glucuronidation of diflunisal in rats.
      J H Lin, I W Chen, E H Ulm and D E Duggan
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1013-1018;

E

  1. Eva, C

    1. In rat hippocampus, somatostatin 14 and muscarinic receptor ligands modulate an adenylate cyclase belonging to a common domain of the receptor.
      C Eva and E Costa
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 888-894;

  2. Evoniuk, G

    1. A1- and A2-selective adenosine antagonists: in vivo characterization of cardiovascular effects.
      G Evoniuk, K A Jacobson, M T Shamim, J W Daly and R J Wurtman
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 882-887;

F

  1. Fee, J D

    1. Selective ganglionic blockade of vagal inputs to sinoatrial and/or atrioventricular regions.
      J D Fee, W C Randall, R D Wurster and J L Ardell
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1006-1012;

  2. Finnegan, K T

    1. 1,2,3,6-tetrahydro-1-methyl-4-(methylpyrrol-2-yl)pyridine: studies on the mechanism of action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
      K T Finnegan, I Irwin, L E Delanney, G A Ricaurte and J W Langston
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1144-1151;

  3. Fisher, D M

    1. Effects of fentanyl on vasopressin secretion in human subjects.
      R B Weiskopf, I A Reid, D M Fisher, M A Holmes, J I Rosen and L C Keil
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 970-973;

  4. Forsythe, M S

    1. Ca++ utilization in the constriction of rat aorta to stimulation of protein kinase C by phorbol dibutyrate.
      A T Chiu, J M Bozarth, M S Forsythe and P B Timmermans
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 934-939;

  5. Francis, J E

    1. Pharmacological characterization of CGS 15943A: a novel nonxanthine adenosine antagonist.
      G Ghai, J E Francis, M Williams, R A Dotson, M F Hopkins, D T Cote, F R Goodman and M B Zimmerman
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 784-790;

  6. Freneaux, E

    1. Inhibition of mitochondrial beta-oxidation of fatty acids by pirprofen. Role in microvesicular steatosis due to this nonsteroidal anti-inflammatory drug.
      J Geneve, B Hayat-Bonan, G Labbe, C Degott, P Letteron, E Freneaux, T L Dinh, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1133-1137;

  7. Fujiwara, M

    1. Impairment of the extraneuronal O-methylating system of isoproterenol by stop-flow ischemia in the perfused rat heart.
      M Inoue, K Hifumi, K Kurahashi and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1086-1089;

G

  1. Galzin, A M

    1. Interaction between neuronal uptake inhibitors and presynaptic serotonin autoreceptors in rat hypothalamic slices: comparison of K+ and electrical depolarization.
      F Passarelli, A M Galzin and S Z Langer
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1056-1063;

  2. Gay, R G

    1. Beta-2 adrenoceptor control of the venous circulation in intact dogs.
      R W Lee, T E Raya, R G Gay, M Olajos and S Goldman
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1138-1143;

  3. Geneve, J

    1. Inhibition of mitochondrial beta-oxidation of fatty acids by pirprofen. Role in microvesicular steatosis due to this nonsteroidal anti-inflammatory drug.
      J Geneve, B Hayat-Bonan, G Labbe, C Degott, P Letteron, E Freneaux, T L Dinh, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1133-1137;

  4. Ghai, G

    1. Pharmacological characterization of CGS 15943A: a novel nonxanthine adenosine antagonist.
      G Ghai, J E Francis, M Williams, R A Dotson, M F Hopkins, D T Cote, F R Goodman and M B Zimmerman
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 784-790;

  5. Giles, R E

    1. ICI 147,798: a novel diuretic agent with beta adrenoceptor blocking activity.
      S T Kau, B B Howe, J H Li, L H Smith, J R Keddie, J J Barlow, R E Giles and M E Goldberg
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 818-826;

  6. Goldberg, L I

    1. Discriminative stimulus properties of D1 and D2 dopamine agonists in rats.
      J B Kamien, L I Goldberg and W L Woolverton
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 804-811;
    2. Mechanisms mediating the positive inotropic and chronotropic changes induced by dopexamine in the anesthetized dog.
      A S Bass, J D Kohli, N Lubbers and L I Goldberg
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 940-944;

  7. Goldberg, M E

    1. ICI 147,798: a novel diuretic agent with beta adrenoceptor blocking activity.
      S T Kau, B B Howe, J H Li, L H Smith, J R Keddie, J J Barlow, R E Giles and M E Goldberg
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 818-826;

  8. Goldman, S

    1. Beta-2 adrenoceptor control of the venous circulation in intact dogs.
      R W Lee, T E Raya, R G Gay, M Olajos and S Goldman
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1138-1143;

  9. Gonzales, R A

    1. Norepinephrine regulation of alpha-1 receptors and alpha-1-stimulated phosphoinositide hydrolysis in primary neuronal cultures.
      R A Gonzales, F T Crews, C Sumners and M K Raizada
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 764-771;

  10. Goodman, F R

    1. Pharmacological characterization of CGS 15943A: a novel nonxanthine adenosine antagonist.
      G Ghai, J E Francis, M Williams, R A Dotson, M F Hopkins, D T Cote, F R Goodman and M B Zimmerman
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 784-790;

  11. Gordon, R K

    1. Comparison of in vitro actions with behavioral effects of antimuscarinic agents.
      J M Witkin, R K Gordon and P K Chiang
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 796-803;

  12. Green, R D

    1. Identification of A1 and A2 adenosine receptors in the rat spinal cord.
      J I Choca, H K Proudfit and R D Green
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 905-910;

H

  1. Haneda, T

    1. Inhibition of ischemia-induced subcellular redistribution of lysosomal enzymes in the perfused rat heart by the calcium entry blocker, diltiazem.
      K Ichihara, T Haneda, S Onodera and Y Abiko
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1109-1113;

  2. Harding, J W

    1. Binding, degradation and pressor activity of angiotensins II and III after aminopeptidase inhibition with amastatin and bestatin.
      R H Abhold, M J Sullivan, J W Wright and J W Harding
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 957-962;

  3. Harris, L T

    1. Effects of serotonin1 and serotonin2 receptor agonists and antagonists on blood pressure, heart rate and sympathetic nerve activity.
      R B McCall, B N Patel and L T Harris
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1152-1159;

  4. Harris, R A

    1. Neurochemical actions of anesthetic drugs on the gamma-aminobutyric acid receptor-chloride channel complex.
      J P Huidobro-Toro, V Bleck, A M Allan and R A Harris
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 963-969;

  5. Hattori, Y

    1. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.
      Y Hattori, I Sakuma, Y Nakao and M Kanno
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1077-1085;

  6. Hayat-Bonan, B

    1. Inhibition of mitochondrial beta-oxidation of fatty acids by pirprofen. Role in microvesicular steatosis due to this nonsteroidal anti-inflammatory drug.
      J Geneve, B Hayat-Bonan, G Labbe, C Degott, P Letteron, E Freneaux, T L Dinh, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1133-1137;

  7. Heikkila, R E

    1. Characteristics of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the mouse.
      P K Sonsalla, S K Youngster, M V Kindt and R E Heikkila
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 850-857;
    2. Mitochondrial and metabolic toxicity of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine.
      M V Kindt, R E Heikkila and W J Nicklas
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 858-863;

  8. Hicks, P E

    1. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
      P E Hicks, I Cavero, P Manoury, F Lefevre-Borg and S Z Langer
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1025-1034;

  9. Hifumi, K

    1. Impairment of the extraneuronal O-methylating system of isoproterenol by stop-flow ischemia in the perfused rat heart.
      M Inoue, K Hifumi, K Kurahashi and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1086-1089;

  10. Holmes, M A

    1. Effects of fentanyl on vasopressin secretion in human subjects.
      R B Weiskopf, I A Reid, D M Fisher, M A Holmes, J I Rosen and L C Keil
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 970-973;

  11. Hopkins, M F

    1. Pharmacological characterization of CGS 15943A: a novel nonxanthine adenosine antagonist.
      G Ghai, J E Francis, M Williams, R A Dotson, M F Hopkins, D T Cote, F R Goodman and M B Zimmerman
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 784-790;

  12. Howe, B B

    1. ICI 147,798: a novel diuretic agent with beta adrenoceptor blocking activity.
      S T Kau, B B Howe, J H Li, L H Smith, J R Keddie, J J Barlow, R E Giles and M E Goldberg
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 818-826;

  13. Hughes, P J

    1. Adenosine inhibits immunoglobulin E-dependent histamine secretion from human basophil leukocytes by two independent mechanisms.
      P J Hughes, R C Benyon and M K Church
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1064-1070;

  14. Huidobro-Toro, J P

    1. Neurochemical actions of anesthetic drugs on the gamma-aminobutyric acid receptor-chloride channel complex.
      J P Huidobro-Toro, V Bleck, A M Allan and R A Harris
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 963-969;

I

  1. Ichihara, K

    1. Inhibition of ischemia-induced subcellular redistribution of lysosomal enzymes in the perfused rat heart by the calcium entry blocker, diltiazem.
      K Ichihara, T Haneda, S Onodera and Y Abiko
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1109-1113;

  2. Inoki, R

    1. Contribution of substance P to heat-induced edema in rat paw.
      N Yonehara, T Shibutani and R Inoki
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1071-1076;

  3. Inoue, M

    1. Impairment of the extraneuronal O-methylating system of isoproterenol by stop-flow ischemia in the perfused rat heart.
      M Inoue, K Hifumi, K Kurahashi and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1086-1089;

  4. Irwin, I

    1. 1,2,3,6-tetrahydro-1-methyl-4-(methylpyrrol-2-yl)pyridine: studies on the mechanism of action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
      K T Finnegan, I Irwin, L E Delanney, G A Ricaurte and J W Langston
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1144-1151;

  5. Iuvone, P M

    1. Regulation of alpha-1 adrenergic receptor density and functional responsiveness in rat brain.
      R D Johnson, P M Iuvone and K P Minneman
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 842-849;

J

  1. Jacobson, K A

    1. A1- and A2-selective adenosine antagonists: in vivo characterization of cardiovascular effects.
      G Evoniuk, K A Jacobson, M T Shamim, J W Daly and R J Wurtman
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 882-887;

  2. James, M K

    1. Analysis of putative alpha-1s adrenoceptor agonism by Sgd 101/75 in the rat anococcygeus muscle.
      M K James and H J Leighton
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 772-776;

  3. Johanson, C E

    1. Reinforcing and subjective effects of several anorectics in normal human volunteers.
      L D Chait, E H Uhlenhuth and C E Johanson
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 777-783;

  4. Johnson, R D

    1. Regulation of alpha-1 adrenergic receptor density and functional responsiveness in rat brain.
      R D Johnson, P M Iuvone and K P Minneman
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 842-849;

  5. Jones, J E

    1. Cytotoxicity of oxidative metabolites of procainamide.
      R L Rubin, J P Uetrecht and J E Jones
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 833-841;

K

  1. Kageyama, M

    1. Diuretic effect induced by intrarenal infusion of pinacidil in anesthetized dogs.
      S Morimoto, Y Matsumura, Y Sasaki, T Takakuwa and M Kageyama
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1050-1055;

  2. Kalivas, P W

    1. Neurochemical and behavioral effects of corticotropin-releasing factor in the ventral tegmental area of the rat.
      P W Kalivas, P Duffy and L G Latimer
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 757-763;

  3. Kamien, J B

    1. Discriminative stimulus properties of D1 and D2 dopamine agonists in rats.
      J B Kamien, L I Goldberg and W L Woolverton
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 804-811;

  4. Kanno, M

    1. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.
      Y Hattori, I Sakuma, Y Nakao and M Kanno
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1077-1085;

  5. Karaki, H

    1. Palytoxin-induced contraction and release of prostaglandins and norepinephrine in the aorta.
      H Nagase and H Karaki
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1120-1125;

  6. Katz, L B

    1. Selective gastric antilesion properties of rioprostil, a prostaglandin E1 analog, in rats and dogs.
      L B Katz, D A Shriver, A J Tobia and M E Rosenthale
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 927-933;

  7. Kau, S T

    1. ICI 147,798: a novel diuretic agent with beta adrenoceptor blocking activity.
      S T Kau, B B Howe, J H Li, L H Smith, J R Keddie, J J Barlow, R E Giles and M E Goldberg
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 818-826;

  8. Kauffman, R F

    1. In vitro vascular relaxation by new inotropic agents: relationship to phosphodiesterase inhibition and cyclic nucleotides.
      R F Kauffman, K W Schenck, B G Utterback, V G Crowe and M L Cohen
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 864-872;

  9. Kazmi, G M

    1. Effects of A23187, exogenous phospholipase A2 and exogenous arachidonic acid on pulmonary vascular resistance in isolated rabbit lung.
      M R Littner, G M Kazmi and F D Lott
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 974-980;

  10. Keddie, J R

    1. ICI 147,798: a novel diuretic agent with beta adrenoceptor blocking activity.
      S T Kau, B B Howe, J H Li, L H Smith, J R Keddie, J J Barlow, R E Giles and M E Goldberg
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 818-826;

  11. Keil, L C

    1. Effects of fentanyl on vasopressin secretion in human subjects.
      R B Weiskopf, I A Reid, D M Fisher, M A Holmes, J I Rosen and L C Keil
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 970-973;

  12. Kindt, M V

    1. Characteristics of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the mouse.
      P K Sonsalla, S K Youngster, M V Kindt and R E Heikkila
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 850-857;
    2. Mitochondrial and metabolic toxicity of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine.
      M V Kindt, R E Heikkila and W J Nicklas
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 858-863;

  13. Kohli, J D

    1. Mechanisms mediating the positive inotropic and chronotropic changes induced by dopexamine in the anesthetized dog.
      A S Bass, J D Kohli, N Lubbers and L I Goldberg
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 940-944;

  14. Kuczenski, R

    1. Individual differences in responsiveness to single and repeated amphetamine administration: behavioral characteristics and neurochemical correlates.
      D S Segal and R Kuczenski
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 917-926;

  15. Kuhar, M J

    1. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
      G Battaglia, S Y Yeh, E O'Hearn, M E Molliver, M J Kuhar and E B De Souza
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 911-916;

  16. Kurahashi, K

    1. Impairment of the extraneuronal O-methylating system of isoproterenol by stop-flow ischemia in the perfused rat heart.
      M Inoue, K Hifumi, K Kurahashi and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1086-1089;

L

  1. Labbe, G

    1. Inhibition of mitochondrial beta-oxidation of fatty acids by pirprofen. Role in microvesicular steatosis due to this nonsteroidal anti-inflammatory drug.
      J Geneve, B Hayat-Bonan, G Labbe, C Degott, P Letteron, E Freneaux, T L Dinh, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1133-1137;

  2. Lafontan, M

    1. Characterization of dog fat cell adrenoceptors: variations in alpha-2 and beta adrenergic receptors distribution according to the extent of the fat deposits and the anatomical location.
      M Taouis, M Berlan, P Montastruc and M Lafontan
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1041-1049;

  3. Lakshmi, V M

    1. Lung prostaglandin H synthase and mixed-function oxidase metabolism of nicotine.
      M B Mattammal, V M Lakshmi, T V Zenser and B B Davis
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 827-832;

  4. Langer, S Z

    1. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
      P E Hicks, I Cavero, P Manoury, F Lefevre-Borg and S Z Langer
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1025-1034;
    2. Interaction between neuronal uptake inhibitors and presynaptic serotonin autoreceptors in rat hypothalamic slices: comparison of K+ and electrical depolarization.
      F Passarelli, A M Galzin and S Z Langer
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1056-1063;

  5. Langston, J W

    1. 1,2,3,6-tetrahydro-1-methyl-4-(methylpyrrol-2-yl)pyridine: studies on the mechanism of action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
      K T Finnegan, I Irwin, L E Delanney, G A Ricaurte and J W Langston
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1144-1151;

  6. Larrey, D

    1. Inhibition of mitochondrial beta-oxidation of fatty acids by pirprofen. Role in microvesicular steatosis due to this nonsteroidal anti-inflammatory drug.
      J Geneve, B Hayat-Bonan, G Labbe, C Degott, P Letteron, E Freneaux, T L Dinh, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1133-1137;

  7. Latimer, L G

    1. Neurochemical and behavioral effects of corticotropin-releasing factor in the ventral tegmental area of the rat.
      P W Kalivas, P Duffy and L G Latimer
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 757-763;

  8. Lee, R W

    1. Beta-2 adrenoceptor control of the venous circulation in intact dogs.
      R W Lee, T E Raya, R G Gay, M Olajos and S Goldman
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1138-1143;

  9. Lefevre-Borg, F

    1. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
      P E Hicks, I Cavero, P Manoury, F Lefevre-Borg and S Z Langer
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1025-1034;

  10. Leighton, H J

    1. Analysis of putative alpha-1s adrenoceptor agonism by Sgd 101/75 in the rat anococcygeus muscle.
      M K James and H J Leighton
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 772-776;

  11. Letteron, P

    1. Inhibition of mitochondrial beta-oxidation of fatty acids by pirprofen. Role in microvesicular steatosis due to this nonsteroidal anti-inflammatory drug.
      J Geneve, B Hayat-Bonan, G Labbe, C Degott, P Letteron, E Freneaux, T L Dinh, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1133-1137;

  12. Li, J H

    1. ICI 147,798: a novel diuretic agent with beta adrenoceptor blocking activity.
      S T Kau, B B Howe, J H Li, L H Smith, J R Keddie, J J Barlow, R E Giles and M E Goldberg
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 818-826;

  13. Lin, C

    1. Characterization of D-2 dopamine receptors in a tumor of the rat anterior pituitary gland.
      C Lin, P McGonigle and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 950-956;

  14. Lin, J H

    1. Differential effects of phenobarbital on ester and ether glucuronidation of diflunisal in rats.
      J H Lin, I W Chen, E H Ulm and D E Duggan
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1013-1018;

  15. Littner, M R

    1. Effects of A23187, exogenous phospholipase A2 and exogenous arachidonic acid on pulmonary vascular resistance in isolated rabbit lung.
      M R Littner, G M Kazmi and F D Lott
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 974-980;

  16. Lott, F D

    1. Effects of A23187, exogenous phospholipase A2 and exogenous arachidonic acid on pulmonary vascular resistance in isolated rabbit lung.
      M R Littner, G M Kazmi and F D Lott
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 974-980;

  17. Lubbers, N

    1. Mechanisms mediating the positive inotropic and chronotropic changes induced by dopexamine in the anesthetized dog.
      A S Bass, J D Kohli, N Lubbers and L I Goldberg
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 940-944;

M

  1. Manoury, P

    1. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
      P E Hicks, I Cavero, P Manoury, F Lefevre-Borg and S Z Langer
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1025-1034;

  2. Matsuda, S P

    1. Relaxing effects of 15-lipoxygenase products of arachidonic acid on rat aorta.
      P Uotila, R Vargas, B Wroblewska, M d'Alarcao, S P Matsuda, E J Corey, C M Cunard and P W Ramwell
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 945-949;

  3. Matsumura, H

    1. Effect of lidocaine on the myocardial acidosis induced by coronary artery occlusion in dogs.
      N Matsumura, H Matsumura and Y Abiko
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1114-1119;

  4. Matsumura, N

    1. Effect of lidocaine on the myocardial acidosis induced by coronary artery occlusion in dogs.
      N Matsumura, H Matsumura and Y Abiko
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1114-1119;

  5. Matsumura, Y

    1. Diuretic effect induced by intrarenal infusion of pinacidil in anesthetized dogs.
      S Morimoto, Y Matsumura, Y Sasaki, T Takakuwa and M Kageyama
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1050-1055;

  6. Mattammal, M B

    1. Lung prostaglandin H synthase and mixed-function oxidase metabolism of nicotine.
      M B Mattammal, V M Lakshmi, T V Zenser and B B Davis
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 827-832;

  7. McCall, R B

    1. Effects of serotonin1 and serotonin2 receptor agonists and antagonists on blood pressure, heart rate and sympathetic nerve activity.
      R B McCall, B N Patel and L T Harris
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1152-1159;

  8. McDonald, J W

    1. Effects of L-652,731, a platelet-activating factor (PAF) receptor antagonist, on PAF- and complement-induced pulmonary hypertension in sheep.
      B W Smallbone, N E Taylor and J W McDonald
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1035-1040;

  9. McGonigle, P

    1. Characterization of D-2 dopamine receptors in a tumor of the rat anterior pituitary gland.
      C Lin, P McGonigle and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 950-956;

  10. Mei, L

    1. Solubilization with digitonin alters the kinetics of pirenzepine binding to muscarinic receptors from rat forebrain and heart.
      J X Wang, L Mei, H I Yamamura and W R Roeske
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 981-990;
    2. Thermodynamic analyses of pirenzepine binding to membrane-bound and solubilized muscarinic receptors from rat forebrain and heart.
      L Mei, J X Wang, W R Roeske and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 991-1000;

  11. Menduke, H

    1. Adenosine mediates the negative chronotropic action of adenosine 5'-triphosphate in the canine sinus node.
      A Pelleg, T Mitsuoka, E L Michelson and H Menduke
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 791-795;

  12. Mezzetti, M

    1. Characteristics and distribution of specific binding sites for leukotriene C4 in human bronchi.
      M Civelli, D Oliva, M Mezzetti and S Nicosia
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1019-1024;

  13. Michelson, E L

    1. Adenosine mediates the negative chronotropic action of adenosine 5'-triphosphate in the canine sinus node.
      A Pelleg, T Mitsuoka, E L Michelson and H Menduke
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 791-795;

  14. Minneman, K P

    1. Regulation of alpha-1 adrenergic receptor density and functional responsiveness in rat brain.
      R D Johnson, P M Iuvone and K P Minneman
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 842-849;

  15. Mitsuoka, T

    1. Adenosine mediates the negative chronotropic action of adenosine 5'-triphosphate in the canine sinus node.
      A Pelleg, T Mitsuoka, E L Michelson and H Menduke
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 791-795;

  16. Molinoff, P B

    1. Characterization of D-2 dopamine receptors in a tumor of the rat anterior pituitary gland.
      C Lin, P McGonigle and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 950-956;

  17. Molliver, M E

    1. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
      G Battaglia, S Y Yeh, E O'Hearn, M E Molliver, M J Kuhar and E B De Souza
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 911-916;

  18. Montastruc, P

    1. Characterization of dog fat cell adrenoceptors: variations in alpha-2 and beta adrenergic receptors distribution according to the extent of the fat deposits and the anatomical location.
      M Taouis, M Berlan, P Montastruc and M Lafontan
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1041-1049;

  19. Morimoto, S

    1. Diuretic effect induced by intrarenal infusion of pinacidil in anesthetized dogs.
      S Morimoto, Y Matsumura, Y Sasaki, T Takakuwa and M Kageyama
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1050-1055;

  20. Munson, A E

    1. Potentiation of the in vitro T-dependent antibody response by the B subunit of cholera toxin.
      K S Campbell and A E Munson
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 895-904;

N

  1. Nagase, H

    1. Palytoxin-induced contraction and release of prostaglandins and norepinephrine in the aorta.
      H Nagase and H Karaki
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1120-1125;

  2. Nakao, Y

    1. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.
      Y Hattori, I Sakuma, Y Nakao and M Kanno
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1077-1085;

  3. Nawrath, H

    1. Effects of (-)-desmethoxyverapamil on heart and vascular smooth muscle.
      H Nawrath and M Raschack
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1090-1097;

  4. Nicklas, W J

    1. Mitochondrial and metabolic toxicity of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine.
      M V Kindt, R E Heikkila and W J Nicklas
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 858-863;

  5. Nicosia, S

    1. Characteristics and distribution of specific binding sites for leukotriene C4 in human bronchi.
      M Civelli, D Oliva, M Mezzetti and S Nicosia
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1019-1024;

O

  1. O'Hearn, E

    1. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
      G Battaglia, S Y Yeh, E O'Hearn, M E Molliver, M J Kuhar and E B De Souza
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 911-916;

  2. Olajos, M

    1. Beta-2 adrenoceptor control of the venous circulation in intact dogs.
      R W Lee, T E Raya, R G Gay, M Olajos and S Goldman
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1138-1143;

  3. Oliva, D

    1. Characteristics and distribution of specific binding sites for leukotriene C4 in human bronchi.
      M Civelli, D Oliva, M Mezzetti and S Nicosia
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1019-1024;

  4. Onodera, S

    1. Inhibition of ischemia-induced subcellular redistribution of lysosomal enzymes in the perfused rat heart by the calcium entry blocker, diltiazem.
      K Ichihara, T Haneda, S Onodera and Y Abiko
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1109-1113;

P

  1. Passarelli, F

    1. Interaction between neuronal uptake inhibitors and presynaptic serotonin autoreceptors in rat hypothalamic slices: comparison of K+ and electrical depolarization.
      F Passarelli, A M Galzin and S Z Langer
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1056-1063;

  2. Patel, B N

    1. Effects of serotonin1 and serotonin2 receptor agonists and antagonists on blood pressure, heart rate and sympathetic nerve activity.
      R B McCall, B N Patel and L T Harris
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1152-1159;

  3. Pearce, W J

    1. Diltiazem and autoregulation of canine cerebral blood flow.
      W J Pearce and J A Bevan
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 812-817;

  4. Pelleg, A

    1. Adenosine mediates the negative chronotropic action of adenosine 5'-triphosphate in the canine sinus node.
      A Pelleg, T Mitsuoka, E L Michelson and H Menduke
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 791-795;

  5. Pessayre, D

    1. Inhibition of mitochondrial beta-oxidation of fatty acids by pirprofen. Role in microvesicular steatosis due to this nonsteroidal anti-inflammatory drug.
      J Geneve, B Hayat-Bonan, G Labbe, C Degott, P Letteron, E Freneaux, T L Dinh, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1133-1137;

  6. Proudfit, H K

    1. Identification of A1 and A2 adenosine receptors in the rat spinal cord.
      J I Choca, H K Proudfit and R D Green
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 905-910;

R

  1. Raizada, M K

    1. Norepinephrine regulation of alpha-1 receptors and alpha-1-stimulated phosphoinositide hydrolysis in primary neuronal cultures.
      R A Gonzales, F T Crews, C Sumners and M K Raizada
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 764-771;

  2. Ramwell, P W

    1. Relaxing effects of 15-lipoxygenase products of arachidonic acid on rat aorta.
      P Uotila, R Vargas, B Wroblewska, M d'Alarcao, S P Matsuda, E J Corey, C M Cunard and P W Ramwell
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 945-949;

  3. Randall, W C

    1. Selective ganglionic blockade of vagal inputs to sinoatrial and/or atrioventricular regions.
      J D Fee, W C Randall, R D Wurster and J L Ardell
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1006-1012;

  4. Raschack, M

    1. Effects of (-)-desmethoxyverapamil on heart and vascular smooth muscle.
      H Nawrath and M Raschack
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1090-1097;

  5. Raya, T E

    1. Beta-2 adrenoceptor control of the venous circulation in intact dogs.
      R W Lee, T E Raya, R G Gay, M Olajos and S Goldman
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1138-1143;

  6. Reid, I A

    1. Effects of fentanyl on vasopressin secretion in human subjects.
      R B Weiskopf, I A Reid, D M Fisher, M A Holmes, J I Rosen and L C Keil
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 970-973;

  7. Ricaurte, G A

    1. 1,2,3,6-tetrahydro-1-methyl-4-(methylpyrrol-2-yl)pyridine: studies on the mechanism of action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
      K T Finnegan, I Irwin, L E Delanney, G A Ricaurte and J W Langston
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1144-1151;

  8. Roeske, W R

    1. Solubilization with digitonin alters the kinetics of pirenzepine binding to muscarinic receptors from rat forebrain and heart.
      J X Wang, L Mei, H I Yamamura and W R Roeske
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 981-990;
    2. Thermodynamic analyses of pirenzepine binding to membrane-bound and solubilized muscarinic receptors from rat forebrain and heart.
      L Mei, J X Wang, W R Roeske and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 991-1000;

  9. Rosen, J I

    1. Effects of fentanyl on vasopressin secretion in human subjects.
      R B Weiskopf, I A Reid, D M Fisher, M A Holmes, J I Rosen and L C Keil
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 970-973;

  10. Rosenthale, M E

    1. Selective gastric antilesion properties of rioprostil, a prostaglandin E1 analog, in rats and dogs.
      L B Katz, D A Shriver, A J Tobia and M E Rosenthale
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 927-933;

  11. Rubin, R L

    1. Cytotoxicity of oxidative metabolites of procainamide.
      R L Rubin, J P Uetrecht and J E Jones
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 833-841;

S

  1. Sakuma, I

    1. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.
      Y Hattori, I Sakuma, Y Nakao and M Kanno
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1077-1085;

  2. Sampson, S R

    1. Effects of ethanol on electrophysiological properties of rat skeletal myotubes in culture.
      C Brodie and S R Sampson
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1098-1103;
    2. Effects of chronic ethanol treatment on membrane potential, its electrogenic pump component and Na-K pump activity of cultured rat skeletal myotubes.
      C Brodie and S R Sampson
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1104-1108;

  3. Sasaki, Y

    1. Diuretic effect induced by intrarenal infusion of pinacidil in anesthetized dogs.
      S Morimoto, Y Matsumura, Y Sasaki, T Takakuwa and M Kageyama
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1050-1055;

  4. Schenck, K W

    1. In vitro vascular relaxation by new inotropic agents: relationship to phosphodiesterase inhibition and cyclic nucleotides.
      R F Kauffman, K W Schenck, B G Utterback, V G Crowe and M L Cohen
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 864-872;

  5. Segal, D S

    1. Individual differences in responsiveness to single and repeated amphetamine administration: behavioral characteristics and neurochemical correlates.
      D S Segal and R Kuczenski
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 917-926;

  6. Shamim, M T

    1. A1- and A2-selective adenosine antagonists: in vivo characterization of cardiovascular effects.
      G Evoniuk, K A Jacobson, M T Shamim, J W Daly and R J Wurtman
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 882-887;

  7. Shibutani, T

    1. Contribution of substance P to heat-induced edema in rat paw.
      N Yonehara, T Shibutani and R Inoki
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1071-1076;

  8. Shriver, D A

    1. Selective gastric antilesion properties of rioprostil, a prostaglandin E1 analog, in rats and dogs.
      L B Katz, D A Shriver, A J Tobia and M E Rosenthale
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 927-933;

  9. Smallbone, B W

    1. Effects of L-652,731, a platelet-activating factor (PAF) receptor antagonist, on PAF- and complement-induced pulmonary hypertension in sheep.
      B W Smallbone, N E Taylor and J W McDonald
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1035-1040;

  10. Smith, L H

    1. ICI 147,798: a novel diuretic agent with beta adrenoceptor blocking activity.
      S T Kau, B B Howe, J H Li, L H Smith, J R Keddie, J J Barlow, R E Giles and M E Goldberg
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 818-826;

  11. Sonsalla, P K

    1. Characteristics of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the mouse.
      P K Sonsalla, S K Youngster, M V Kindt and R E Heikkila
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 850-857;

  12. Sperelakis, N

    1. Bupivacaine and lidocaine blockade of calcium-mediated slow action potentials in guinea pig ventricular muscle.
      D E Coyle and N Sperelakis
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1001-1005;

  13. Sullivan, M J

    1. Binding, degradation and pressor activity of angiotensins II and III after aminopeptidase inhibition with amastatin and bestatin.
      R H Abhold, M J Sullivan, J W Wright and J W Harding
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 957-962;

  14. Sumners, C

    1. Norepinephrine regulation of alpha-1 receptors and alpha-1-stimulated phosphoinositide hydrolysis in primary neuronal cultures.
      R A Gonzales, F T Crews, C Sumners and M K Raizada
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 764-771;

T

  1. Takakuwa, T

    1. Diuretic effect induced by intrarenal infusion of pinacidil in anesthetized dogs.
      S Morimoto, Y Matsumura, Y Sasaki, T Takakuwa and M Kageyama
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1050-1055;

  2. Taouis, M

    1. Characterization of dog fat cell adrenoceptors: variations in alpha-2 and beta adrenergic receptors distribution according to the extent of the fat deposits and the anatomical location.
      M Taouis, M Berlan, P Montastruc and M Lafontan
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1041-1049;

  3. Taylor, N E

    1. Effects of L-652,731, a platelet-activating factor (PAF) receptor antagonist, on PAF- and complement-induced pulmonary hypertension in sheep.
      B W Smallbone, N E Taylor and J W McDonald
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1035-1040;

  4. Timmermans, P B

    1. Ca++ utilization in the constriction of rat aorta to stimulation of protein kinase C by phorbol dibutyrate.
      A T Chiu, J M Bozarth, M S Forsythe and P B Timmermans
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 934-939;

  5. Tobia, A J

    1. Selective gastric antilesion properties of rioprostil, a prostaglandin E1 analog, in rats and dogs.
      L B Katz, D A Shriver, A J Tobia and M E Rosenthale
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 927-933;

  6. Turner, J T

    1. Characterization of the vasoactive intestinal peptide receptor in rat submandibular gland: radioligand binding assay in membrane preparations.
      J T Turner and D B Bylund
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 873-881;

U

  1. Uetrecht, J P

    1. Cytotoxicity of oxidative metabolites of procainamide.
      R L Rubin, J P Uetrecht and J E Jones
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 833-841;

  2. Uhlenhuth, E H

    1. Reinforcing and subjective effects of several anorectics in normal human volunteers.
      L D Chait, E H Uhlenhuth and C E Johanson
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 777-783;

  3. Ulm, E H

    1. Differential effects of phenobarbital on ester and ether glucuronidation of diflunisal in rats.
      J H Lin, I W Chen, E H Ulm and D E Duggan
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1013-1018;

  4. Uotila, P

    1. Relaxing effects of 15-lipoxygenase products of arachidonic acid on rat aorta.
      P Uotila, R Vargas, B Wroblewska, M d'Alarcao, S P Matsuda, E J Corey, C M Cunard and P W Ramwell
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 945-949;

  5. Utterback, B G

    1. In vitro vascular relaxation by new inotropic agents: relationship to phosphodiesterase inhibition and cyclic nucleotides.
      R F Kauffman, K W Schenck, B G Utterback, V G Crowe and M L Cohen
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 864-872;

V

  1. Vargas, R

    1. Relaxing effects of 15-lipoxygenase products of arachidonic acid on rat aorta.
      P Uotila, R Vargas, B Wroblewska, M d'Alarcao, S P Matsuda, E J Corey, C M Cunard and P W Ramwell
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 945-949;

W

  1. Wang, J X

    1. Solubilization with digitonin alters the kinetics of pirenzepine binding to muscarinic receptors from rat forebrain and heart.
      J X Wang, L Mei, H I Yamamura and W R Roeske
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 981-990;
    2. Thermodynamic analyses of pirenzepine binding to membrane-bound and solubilized muscarinic receptors from rat forebrain and heart.
      L Mei, J X Wang, W R Roeske and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 991-1000;

  2. Weiskopf, R B

    1. Effects of fentanyl on vasopressin secretion in human subjects.
      R B Weiskopf, I A Reid, D M Fisher, M A Holmes, J I Rosen and L C Keil
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 970-973;

  3. Williams, M

    1. Pharmacological characterization of CGS 15943A: a novel nonxanthine adenosine antagonist.
      G Ghai, J E Francis, M Williams, R A Dotson, M F Hopkins, D T Cote, F R Goodman and M B Zimmerman
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 784-790;

  4. Witkin, J M

    1. Comparison of in vitro actions with behavioral effects of antimuscarinic agents.
      J M Witkin, R K Gordon and P K Chiang
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 796-803;

  5. Woolverton, W L

    1. Discriminative stimulus properties of D1 and D2 dopamine agonists in rats.
      J B Kamien, L I Goldberg and W L Woolverton
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 804-811;

  6. Wright, J W

    1. Binding, degradation and pressor activity of angiotensins II and III after aminopeptidase inhibition with amastatin and bestatin.
      R H Abhold, M J Sullivan, J W Wright and J W Harding
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 957-962;

  7. Wroblewska, B

    1. Relaxing effects of 15-lipoxygenase products of arachidonic acid on rat aorta.
      P Uotila, R Vargas, B Wroblewska, M d'Alarcao, S P Matsuda, E J Corey, C M Cunard and P W Ramwell
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 945-949;

  8. Wurster, R D

    1. Selective ganglionic blockade of vagal inputs to sinoatrial and/or atrioventricular regions.
      J D Fee, W C Randall, R D Wurster and J L Ardell
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1006-1012;

  9. Wurtman, R J

    1. A1- and A2-selective adenosine antagonists: in vivo characterization of cardiovascular effects.
      G Evoniuk, K A Jacobson, M T Shamim, J W Daly and R J Wurtman
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 882-887;

Y

  1. Yamamura, H I

    1. Solubilization with digitonin alters the kinetics of pirenzepine binding to muscarinic receptors from rat forebrain and heart.
      J X Wang, L Mei, H I Yamamura and W R Roeske
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 981-990;
    2. Thermodynamic analyses of pirenzepine binding to membrane-bound and solubilized muscarinic receptors from rat forebrain and heart.
      L Mei, J X Wang, W R Roeske and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 991-1000;

  2. Yeh, S Y

    1. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
      G Battaglia, S Y Yeh, E O'Hearn, M E Molliver, M J Kuhar and E B De Souza
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 911-916;

  3. Yonehara, N

    1. Contribution of substance P to heat-induced edema in rat paw.
      N Yonehara, T Shibutani and R Inoki
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1071-1076;

  4. Younes, A

    1. Protective effects of bepridil on calcium injury of anoxic myocytes isolated from adult rat heart ventricular muscle.
      C Cruz, A Zaoui, G Berson and A Younes
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1126-1132;

  5. Youngster, S K

    1. Characteristics of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the mouse.
      P K Sonsalla, S K Youngster, M V Kindt and R E Heikkila
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 850-857;

Z

  1. Zaoui, A

    1. Protective effects of bepridil on calcium injury of anoxic myocytes isolated from adult rat heart ventricular muscle.
      C Cruz, A Zaoui, G Berson and A Younes
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 1126-1132;

  2. Zenser, T V

    1. Lung prostaglandin H synthase and mixed-function oxidase metabolism of nicotine.
      M B Mattammal, V M Lakshmi, T V Zenser and B B Davis
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 827-832;

  3. Zimmerman, M B

    1. Pharmacological characterization of CGS 15943A: a novel nonxanthine adenosine antagonist.
      G Ghai, J E Francis, M Williams, R A Dotson, M F Hopkins, D T Cote, F R Goodman and M B Zimmerman
      Journal of Pharmacology and Experimental Therapeutics September 1987, 242 (3) 784-790;
Back to top

In this issue

Advertisement